| dna metabolic process | GO:0006259 | 303 | 0.945 | |
| double strand break repair | GO:0006302 | 48 | 0.840 | Human Yeast |
| meiosis i | GO:0007127 | 60 | 0.772 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.725 | Yeast |
| telomere capping | GO:0016233 | 4 | 0.564 | |
| dna dependent dna replication | GO:0006261 | 24 | 0.546 | Human |
| chromosome organization involved in meiosis | GO:0070192 | 39 | 0.425 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.416 | Yeast |
| meiotic chromosome segregation | GO:0045132 | 19 | 0.357 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.305 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.301 | |
| synapsis | GO:0007129 | 34 | 0.283 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.274 | |
| dna replication | GO:0006260 | 52 | 0.259 | |
| gonad development | GO:0008406 | 141 | 0.253 | |
| dna conformation change | GO:0071103 | 37 | 0.244 | |
| protein import into nucleus | GO:0006606 | 95 | 0.226 | |
| dna biosynthetic process | GO:0071897 | 22 | 0.225 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.218 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.188 | Worm |
| dna repair | GO:0006281 | 107 | 0.188 | Human Yeast |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.177 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.175 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.171 | |
| double strand break repair via homologous recombination | GO:0000724 | 21 | 0.164 | |
| endocytosis | GO:0006897 | 168 | 0.155 | |
| receptor mediated endocytosis | GO:0006898 | 51 | 0.154 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.146 | |
| organelle assembly | GO:0070925 | 177 | 0.145 | |
| protein targeting | GO:0006605 | 143 | 0.145 | |
| recombinational repair | GO:0000725 | 21 | 0.145 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.140 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.135 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.133 | |
| membrane organization | GO:0061024 | 245 | 0.131 | |
| nuclear transport | GO:0051169 | 139 | 0.129 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.116 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.114 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.112 | |
| dna endoreduplication | GO:0042023 | 4 | 0.109 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.108 | |
| regulation of dna dependent dna replication | GO:0090329 | 8 | 0.107 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.106 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.105 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.101 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.101 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.097 | |
| protein catabolic process | GO:0030163 | 221 | 0.095 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.093 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.093 | |
| cellular response to radiation | GO:0071478 | 28 | 0.092 | |
| intracellular protein transport | GO:0006886 | 204 | 0.091 | |
| protein import | GO:0017038 | 101 | 0.090 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.088 | |
| maintenance of location | GO:0051235 | 89 | 0.087 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.087 | |
| microtubule organizing center organization | GO:0031023 | 28 | 0.086 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.084 | |
| intra s dna damage checkpoint | GO:0031573 | 4 | 0.083 | |
| single organism nuclear import | GO:1902593 | 95 | 0.083 | |
| mitotic chromosome condensation | GO:0007076 | 1 | 0.082 | |
| nuclear import | GO:0051170 | 95 | 0.082 | |
| microtubule based process | GO:0007017 | 236 | 0.079 | |
| reciprocal dna recombination | GO:0035825 | 16 | 0.078 | |
| female meiotic division | GO:0007143 | 21 | 0.077 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.076 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.074 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.073 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.073 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.072 | |
| dna packaging | GO:0006323 | 30 | 0.072 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.070 | |
| genitalia development | GO:0048806 | 37 | 0.069 | |
| amine metabolic process | GO:0009308 | 45 | 0.068 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.068 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.068 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.066 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.065 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.065 | |
| telomere maintenance | GO:0000723 | 19 | 0.065 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.064 | Human Yeast |
| regulation of meiosis i | GO:0060631 | 7 | 0.064 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.063 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.063 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.062 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.060 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.059 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.058 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.056 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.056 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.055 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.054 | |
| male meiosis | GO:0007140 | 37 | 0.054 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.054 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.053 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.053 | |
| cell division | GO:0051301 | 120 | 0.052 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.052 | |
| nucleic acid phosphodiester bond hydrolysis | GO:0090305 | 49 | 0.052 | |
| male gamete generation | GO:0048232 | 285 | 0.051 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.051 | |
| spermatogenesis | GO:0007283 | 284 | 0.050 | |
| female meiosis chromosome segregation | GO:0016321 | 1 | 0.050 | |
| organelle fission | GO:0048285 | 170 | 0.050 | |
| cellular response to ionizing radiation | GO:0071479 | 11 | 0.049 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.049 | |
| protein localization to organelle | GO:0033365 | 185 | 0.049 | |
| mitotic g2 dna damage checkpoint | GO:0007095 | 8 | 0.049 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.048 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.048 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.046 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.046 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.046 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.046 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.046 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.045 | |
| regulation of mitosis | GO:0007088 | 29 | 0.045 | |
| regulation of cell division | GO:0051302 | 76 | 0.044 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.044 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.044 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 45 | 0.043 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.043 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.042 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.041 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.041 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.041 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.041 | |
| response to radiation | GO:0009314 | 165 | 0.041 | |
| negative regulation of cell cycle process | GO:0010948 | 69 | 0.041 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.041 | |
| spindle assembly involved in female meiosis | GO:0007056 | 3 | 0.040 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.040 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.040 | |
| centrosome organization | GO:0051297 | 26 | 0.039 | |
| cell fate commitment | GO:0045165 | 210 | 0.039 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.039 | |
| mitotic cytokinesis | GO:0000281 | 4 | 0.039 | |
| spindle assembly involved in meiosis | GO:0090306 | 4 | 0.038 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.038 | |
| regulation of centriole replication | GO:0046599 | 1 | 0.037 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.036 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.036 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.035 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.035 | |
| mitochondrion organization | GO:0007005 | 134 | 0.034 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.034 | |
| translesion synthesis | GO:0019985 | 1 | 0.034 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.034 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.033 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.032 | |
| regulation of dna replication | GO:0006275 | 17 | 0.032 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.032 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.032 | |
| spindle assembly involved in mitosis | GO:0090307 | 4 | 0.032 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.032 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.032 | |
| negative regulation of meiotic cell cycle | GO:0051447 | 14 | 0.031 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.031 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.031 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.031 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.030 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.030 | |
| nuclear dna replication | GO:0033260 | 3 | 0.030 | |
| germ cell development | GO:0007281 | 185 | 0.029 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.029 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.029 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.029 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.029 | |
| mitotic recombination | GO:0006312 | 3 | 0.028 | |
| heterochromatin assembly | GO:0031507 | 2 | 0.028 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.028 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.027 | |
| dna catabolic process | GO:0006308 | 19 | 0.027 | |
| multicellular organism growth | GO:0035264 | 161 | 0.027 | |
| protein oligomerization | GO:0051259 | 67 | 0.027 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.027 | |
| chromosome segregation | GO:0007059 | 48 | 0.026 | |
| negative regulation of dna dependent dna replication | GO:2000104 | 1 | 0.026 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.026 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.026 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.026 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.026 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.026 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.025 | |
| regulation of protein localization | GO:0032880 | 231 | 0.025 | |
| regulation of dna recombination | GO:0000018 | 34 | 0.025 | |
| microtubule cytoskeleton organization involved in mitosis | GO:1902850 | 4 | 0.025 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.024 | |
| protein autophosphorylation | GO:0046777 | 61 | 0.024 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.024 | |
| innate immune response | GO:0045087 | 157 | 0.024 | |
| myosin filament organization | GO:0031033 | 3 | 0.024 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.024 | |
| cell cycle checkpoint | GO:0000075 | 47 | 0.024 | |
| heterochromatin organization | GO:0070828 | 4 | 0.024 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.023 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.023 | |
| negative regulation of nuclear division | GO:0051784 | 19 | 0.023 | |
| chromatin assembly or disassembly | GO:0006333 | 16 | 0.023 | |
| t cell apoptotic process | GO:0070231 | 39 | 0.023 | |
| response to light stimulus | GO:0009416 | 135 | 0.023 | |
| mrna 3 end processing | GO:0031124 | 16 | 0.023 | |
| response to oxidative stress | GO:0006979 | 123 | 0.023 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.022 | |
| response to denervation involved in regulation of muscle adaptation | GO:0014894 | 4 | 0.022 | |
| dna catabolic process endonucleolytic | GO:0000737 | 15 | 0.022 | |
| reciprocal meiotic recombination | GO:0007131 | 16 | 0.022 | |
| dna recombination | GO:0006310 | 92 | 0.021 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.021 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.021 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.021 | |
| dna dependent dna replication maintenance of fidelity | GO:0045005 | 3 | 0.021 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.021 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.021 | |
| lateral inhibition | GO:0046331 | 1 | 0.021 | |
| striated muscle cell development | GO:0055002 | 125 | 0.021 | |
| methylation | GO:0032259 | 134 | 0.021 | |
| protein maturation | GO:0051604 | 176 | 0.021 | |
| neuron death | GO:0070997 | 154 | 0.021 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.020 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.020 | |
| response to uv | GO:0009411 | 44 | 0.020 | |
| regulation of nuclear cell cycle dna replication | GO:0033262 | 2 | 0.020 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.020 | |
| placenta development | GO:0001890 | 140 | 0.020 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.020 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.020 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.020 | |
| regulation of protein depolymerization | GO:1901879 | 26 | 0.019 | |
| regulation of transcription by chromatin organization | GO:0034401 | 0 | 0.019 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.019 | |
| sister chromatid segregation | GO:0000819 | 20 | 0.019 | |
| chromatin organization | GO:0006325 | 206 | 0.019 | |
| regulation of histone modification | GO:0031056 | 56 | 0.019 | |
| response to inorganic substance | GO:0010035 | 96 | 0.019 | |
| cellular protein complex disassembly | GO:0043624 | 36 | 0.019 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.018 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.018 | |
| double strand break repair via nonhomologous end joining | GO:0006303 | 10 | 0.018 | Human |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.018 | |
| membrane invagination | GO:0010324 | 17 | 0.018 | |
| compound eye development | GO:0048749 | 1 | 0.018 | |
| dna methylation | GO:0006306 | 43 | 0.018 | |
| muscle tissue development | GO:0060537 | 308 | 0.018 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.018 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.018 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.018 | |
| dna modification | GO:0006304 | 50 | 0.018 | |
| protein secretion | GO:0009306 | 111 | 0.018 | |
| regulation of neuron death | GO:1901214 | 134 | 0.018 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.017 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.017 | |
| atp catabolic process | GO:0006200 | 55 | 0.017 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.017 | |
| cdc42 protein signal transduction | GO:0032488 | 0 | 0.017 | |
| sensory perception | GO:0007600 | 245 | 0.017 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.017 | |
| cell aging | GO:0007569 | 35 | 0.017 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.017 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.017 | |
| negative regulation of dna replication | GO:0008156 | 4 | 0.017 | |
| regulation of dna endoreduplication | GO:0032875 | 3 | 0.017 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.016 | |
| female gamete generation | GO:0007292 | 74 | 0.016 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.016 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.016 | |
| nuclear division | GO:0000280 | 158 | 0.016 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.016 | |
| digestive system development | GO:0055123 | 200 | 0.016 | |
| dna duplex unwinding | GO:0032508 | 7 | 0.016 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.016 | |
| locomotory behavior | GO:0007626 | 195 | 0.016 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.016 | |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.016 | |
| response to purine containing compound | GO:0014074 | 28 | 0.016 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.015 | |
| regulation of chromatin silencing | GO:0031935 | 2 | 0.015 | |
| interleukin 1 alpha secretion | GO:0050703 | 3 | 0.015 | |
| negative regulation of microtubule polymerization or depolymerization | GO:0031111 | 15 | 0.015 | |
| myosin filament assembly | GO:0031034 | 2 | 0.015 | |
| muscle cell development | GO:0055001 | 133 | 0.015 | |
| angiogenesis | GO:0001525 | 201 | 0.015 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.015 | |
| apoptotic mitochondrial changes | GO:0008637 | 48 | 0.015 | |
| response to growth factor | GO:0070848 | 198 | 0.015 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.015 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.015 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.015 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.015 | |
| cytokinetic process | GO:0032506 | 2 | 0.015 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.015 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.015 | |
| developmental maturation | GO:0021700 | 193 | 0.014 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.014 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.014 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.014 | |
| nucleus organization | GO:0006997 | 45 | 0.014 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.014 | |
| axonogenesis | GO:0007409 | 274 | 0.014 | |
| endomembrane system organization | GO:0010256 | 147 | 0.014 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.014 | |
| protein import into nucleus translocation | GO:0000060 | 12 | 0.014 | |
| kinetochore organization | GO:0051383 | 2 | 0.014 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.014 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.014 | |
| dna alkylation | GO:0006305 | 43 | 0.014 | |
| response to topologically incorrect protein | GO:0035966 | 25 | 0.014 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.013 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.013 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.013 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.013 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.013 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.013 | |
| developmental cell growth | GO:0048588 | 84 | 0.013 | |
| regulation of cell motility | GO:2000145 | 236 | 0.013 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.013 | |
| organelle localization | GO:0051640 | 179 | 0.013 | Worm |
| response to ionizing radiation | GO:0010212 | 42 | 0.013 | |
| dendrite development | GO:0016358 | 115 | 0.013 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.013 | |
| dna damage checkpoint | GO:0000077 | 26 | 0.013 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.013 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.013 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 39 | 0.013 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.013 | |
| inflammatory response | GO:0006954 | 244 | 0.013 | |
| regulation of protein localization to nucleus | GO:1900180 | 60 | 0.013 | |
| regulation of protein transport | GO:0051223 | 163 | 0.013 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.013 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.013 | |
| atp metabolic process | GO:0046034 | 75 | 0.012 | |
| neuron migration | GO:0001764 | 122 | 0.012 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.012 | |
| mapk cascade | GO:0000165 | 281 | 0.012 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.012 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.012 | |
| viral entry into host cell | GO:0046718 | 15 | 0.012 | |
| male meiosis i | GO:0007141 | 16 | 0.012 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.012 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.012 | |
| negative regulation of cell division | GO:0051782 | 24 | 0.012 | |
| er nucleus signaling pathway | GO:0006984 | 27 | 0.012 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.012 | |
| rna catabolic process | GO:0006401 | 29 | 0.012 | |
| cytokine production | GO:0001816 | 319 | 0.012 | |
| phagocytosis | GO:0006909 | 66 | 0.012 | |
| apoptotic nuclear changes | GO:0030262 | 9 | 0.012 | |
| cellular response to lipid | GO:0071396 | 145 | 0.012 | |
| positive regulation of rac gtpase activity | GO:0032855 | 14 | 0.012 | |
| gene silencing | GO:0016458 | 38 | 0.012 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.012 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.012 | |
| centromere complex assembly | GO:0034508 | 3 | 0.012 | |
| regulation of cell activation | GO:0050865 | 289 | 0.012 | |
| dna replication initiation | GO:0006270 | 5 | 0.012 | Human |
| spermatid development | GO:0007286 | 108 | 0.012 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.012 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.012 | |
| zymogen activation | GO:0031638 | 41 | 0.012 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.012 | |
| cell maturation | GO:0048469 | 127 | 0.012 | |
| mitotic cell cycle checkpoint | GO:0007093 | 31 | 0.012 | |
| embryonic placenta development | GO:0001892 | 98 | 0.012 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.012 | |
| dna hypermethylation | GO:0044026 | 3 | 0.011 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.011 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.011 | |
| urogenital system development | GO:0001655 | 261 | 0.011 | |
| establishment or maintenance of microtubule cytoskeleton polarity | GO:0030951 | 1 | 0.011 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.011 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.011 | |
| histone modification | GO:0016570 | 159 | 0.011 | |
| regulation of binding | GO:0051098 | 111 | 0.011 | |
| cellular response to peptide | GO:1901653 | 92 | 0.011 | |
| srebp signaling pathway | GO:0032933 | 4 | 0.011 | |
| cellular component disassembly involved in execution phase of apoptosis | GO:0006921 | 9 | 0.011 | |
| response to steroid hormone | GO:0048545 | 56 | 0.011 | |
| apoptotic dna fragmentation | GO:0006309 | 7 | 0.011 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.011 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.011 | |
| adult behavior | GO:0030534 | 135 | 0.011 | |
| rna 3 end processing | GO:0031123 | 20 | 0.011 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.011 | |
| regulation of interleukin 1 alpha production | GO:0032650 | 4 | 0.011 | |
| response to hypoxia | GO:0001666 | 58 | 0.011 | |
| anion transport | GO:0006820 | 177 | 0.011 | |
| neural tube formation | GO:0001841 | 108 | 0.011 | |
| apoptotic cell clearance | GO:0043277 | 17 | 0.011 | |
| negative regulation of meiotic cell cycle phase transition | GO:1901994 | 3 | 0.011 | |
| multi organism behavior | GO:0051705 | 62 | 0.011 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.011 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.011 | |
| regulation of lymphocyte apoptotic process | GO:0070228 | 41 | 0.011 | |
| b cell activation | GO:0042113 | 161 | 0.011 | |
| metaphase plate congression | GO:0051310 | 2 | 0.011 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.010 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.010 | |
| response to endoplasmic reticulum stress | GO:0034976 | 53 | 0.010 | |
| skin development | GO:0043588 | 220 | 0.010 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.010 | |
| meiotic chromosome condensation | GO:0010032 | 3 | 0.010 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.010 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.010 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.010 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.010 | |
| mitotic centrosome separation | GO:0007100 | 4 | 0.010 | |
| regulation of cell migration | GO:0030334 | 219 | 0.010 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.010 | |
| mrna processing | GO:0006397 | 63 | 0.010 | |
| sensory perception of sound | GO:0007605 | 97 | 0.010 | |
| gtp catabolic process | GO:0006184 | 143 | 0.010 | |
| macromolecular complex disassembly | GO:0032984 | 43 | 0.010 | |
